Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Med Case Rep. 2011 Nov 10;5:548. doi: 10.1186/1752-1947-5-548.

Reversible cerebral vasoconstriction syndrome in a patient taking citalopram and Hydroxycut: a case report.

Author information

  • 1Department of Neurology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. Gregory_cvetanovich@hms.harvard.edu.

Abstract

INTRODUCTION:

Reversible cerebral vasoconstriction syndrome presents with thunderclap headaches accompanied by mild neurologic deficits and is characterized by multifocal narrowing of the cerebral arteries that resolves over days to weeks. This syndrome may be idiopathic or occur in special contexts, most often involving adrenergic or serotonergic overactivity. To the best of our knowledge, reversible cerebral vasoconstriction syndrome has not previously been reported in association with Hydroxycut use in the literature.

CASE PRESENTATION:

We report the case of a 65-year-old Caucasian woman on longstanding citalopram who developed reversible cerebral vasoconstriction syndrome two weeks after beginning to take the weight-loss supplement Hydroxycut.

CONCLUSION:

There are sparse data about the safety of herbal supplements such as Hydroxycut, even though the Food and Drug Administration has banned some herbal ingredients, such as ephedra, that were in this preparation in the past. This case highlights the importance of considering herbal supplements and potential drug interactions in the genesis of otherwise unexplained reversible cerebral vasoconstriction syndrome.

PMID:
22074635
[PubMed]
PMCID:
PMC3260136
Free PMC Article

Images from this publication.See all images (2)Free text

Figure 1
Figure 2
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Write to the Help Desk